As of 2026-02-14, the Relative Valuation of Renalytix AI PLC (RENX.L) is (73.96) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 4.12 GBP, the upside of Renalytix AI PLC based on Relative Valuation is -1893.0%.
The range of the Relative Valuation is (66.60) - (83.86) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 37.4x | 28.0x |
| Forward P/E multiples | 27.8x - 35.0x | 33.7x |
| Fair Price | (66.60) - (83.86) | (73.96) |
| Upside | -1714.6% - -2133.1% | -1893.0% |
| Date | P/E |
| 2026-02-11 | -1.27 |
| 2026-02-10 | -1.72 |
| 2026-02-09 | -1.79 |
| 2026-02-06 | -1.80 |
| 2026-02-05 | -1.72 |
| 2026-02-04 | -1.70 |
| 2026-02-03 | -1.63 |
| 2026-02-02 | -1.77 |
| 2026-01-30 | -1.78 |
| 2026-01-29 | -1.81 |
| 2026-01-28 | -1.81 |
| 2026-01-27 | -1.82 |
| 2026-01-26 | -1.93 |
| 2026-01-23 | -1.94 |
| 2026-01-22 | -1.92 |
| 2026-01-21 | -1.92 |
| 2026-01-20 | -1.92 |
| 2026-01-19 | -1.93 |
| 2026-01-16 | -1.94 |
| 2026-01-15 | -1.89 |
| 2026-01-14 | -1.92 |
| 2026-01-13 | -1.92 |
| 2026-01-12 | -1.93 |
| 2026-01-09 | -1.94 |
| 2026-01-08 | -1.92 |
| 2026-01-07 | -1.81 |
| 2026-01-06 | -1.82 |
| 2026-01-05 | -1.82 |
| 2026-01-02 | -1.83 |
| 2025-12-31 | -1.81 |
| 2025-12-30 | -1.85 |
| 2025-12-29 | -1.79 |
| 2025-12-24 | -1.81 |
| 2025-12-23 | -1.82 |
| 2025-12-22 | -1.93 |
| 2025-12-19 | -1.94 |
| 2025-12-18 | -1.84 |
| 2025-12-17 | -1.92 |
| 2025-12-16 | -1.92 |
| 2025-12-15 | -1.93 |
| 2025-12-12 | -1.94 |
| 2025-12-11 | -1.92 |
| 2025-12-10 | -1.92 |
| 2025-12-09 | -1.92 |
| 2025-12-08 | -2.08 |
| 2025-12-05 | -2.09 |
| 2025-12-04 | -2.07 |
| 2025-12-03 | -2.07 |
| 2025-12-02 | -2.08 |
| 2025-12-01 | -2.08 |